Plus Therapeutics Inc (NASDAQ:PSTV) does about 14.77M shares in volume on a normal day but saw 2764100 shares change hands in the recent trading day. The company now has a market cap of 10.65M USD. Its current market price is $0.33, marking an increase of 2.04% compared to the previous close of $0.32. The 52 week high reached by this stock is $2.58 whilst the lowest price level in 52 weeks is $0.24.
The consensus objective for the share price is $9.75, suggesting that the stock has a potential upside of 96.62% over the period.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on March 17, 2025 when D. Boral Capital initiated the stock to “Buy” and issued a price target of $9. Maxim Group initiated its price target at $6.
The current price level is -18.03%, -48.57%, and -70.43% away from its SMA20, SMA50, and SMA200 respectively, with the PSTV price moving above the 50-day SMA on current market day. Plus Therapeutics Inc (PSTV) stock is up 13.45% over the week and -42.25% over the past month. Its price is -71.70% year-to-date and -87.48% over the past year.
The company’s next earnings report forecasts estimating quarterly EPS at -0.23 and -0.83 for whole year. Expected sales for next quarter are $1.29M, which analysts say will come at $4.61M for the current fiscal year and next year at $5.03M. In addition, estimates put the company’s current quarterly revenue at an average of $1.04M.
To reach the target analysts have set, the stock logically needs to grow 96.62 percent from here.
Outstanding shares total 32.72M with insiders holding 9.29% of the shares and institutional holders owning 3.90% of the company’s common stock. The beta has a value of 0.63. Price to sales ratio is 2.04.
